Enabling Technologies for Personalized and Precision MedicineDean Ho, Ali Zarrinpar, Edward R.B. McCabe et al.|Trends in biotechnology|2020Cited by 483
Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D modelsJingru Xu, Edward Kai‐Hua Chow|Nanoscale|2021Cited by 42
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitorsJhin Jieh Lim, Edward Kai‐Hua Chow|Journal of Experimental & Clinical Cancer Research|2022Cited by 32
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaXi Yun Zhang, Edward Kai‐Hua Chow|Experimental Hematology and Oncology|2020Cited by 21
Histone‐lysine N‐methyltransferase <i>EHMT2</i> (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancerDexter Kai Hao Thng, Edward Kai‐Hua Chow|Molecular Oncology|2023Cited by 18